Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems has successfully completed an upsized offering of $460 million in 0% convertible senior notes due 2026. The offering includes $60 million from the initial purchasers' option. The notes do not accrue interest and will mature on November 15, 2026. They have an initial conversion rate of 27.8364 shares per $1,000 principal amount, representing a 42.5% premium over the recent stock price. Net proceeds of approximately $446 million will be used for general corporate purposes, including potential acquisitions. The offering was made to qualified institutional buyers under Rule 144A.
3D Systems (NYSE: DDD) has unveiled several innovations aimed at advancing additive manufacturing across healthcare and industrial sectors. Key highlights include the launch of the SLS 380 for enhanced part production, the DMP Flex 350 Dual and DMP Factory 350 Dual which reduce build times significantly, and the DMP Flex 200 optimized for dental applications. Additional advancements include the 3DXpert® 17 software for improved design workflows and the Figure 4® Rigid 140C Black material for automotive applications, showcasing the company's commitment to delivering innovative solutions in 3D printing.
3D Systems has priced its offering of $400 million in 0% convertible senior notes due 2026, raising the initial offering from $350 million. The sale is expected to close on November 16, 2021. The notes, with a conversion rate of 27.8364 shares per $1,000 principal, represent a 42.5% premium over the recent stock price. Estimated net proceeds are around $388 million, intended for general corporate purposes, including potential acquisitions. The offering is made under Rule 144A and involves risks that could affect the company's future performance.
3D Systems announced a proposed offering of $350 million of convertible senior notes due 2026. An additional $52.5 million may be purchased by initial investors within 13 days of issuance. The notes will be unsecured and interest will be paid semiannually. They can be converted under certain conditions until 2026, upon which 3D Systems may pay cash, stock, or a combination upon conversion. The net proceeds will support general corporate purposes, including potential acquisitions. This offering is private and subject to market conditions.
3D Systems Corporation (NYSE:DDD) reported Q3 2021 revenue of $156.1 million, reflecting a 14.6% increase year-over-year. Adjusted for divestitures, revenue grew 35.9% compared to 2020. The company achieved a 10.5% adjusted EBITDA margin and generated $20.7 million in positive cash flow, marking four consecutive quarters of positive operations. Following divestitures, cash reserves stand at $502.8 million with no debt. 3D Systems announced acquisitions of Oqton and Volumetric Biotechnologies to drive future high-margin growth. Gross profit margin was 41.2%.
3D Systems announces an expansion of its collaboration with United Therapeutics to develop bioprinting technology for multiple human organs, beyond just lungs. This amendment will take effect once 3D Systems completes its acquisition of Volumetric Biotechnologies, Inc. The program aims to provide an unlimited supply of biocompatible human organs for transplantation, relying on a technology platform established since 2017. The initiative is projected to continue through 2025, reflecting the companies' commitment to addressing urgent medical needs for organ transplants.
Volumetric, a Houston-based biofabrication start-up, has been acquired by 3D Systems (NYSE: DDD) for an initial payment of
3D Systems has announced the acquisition of Volumetric Biotechnologies for an initial payment of $45 million, with a potential total value of $400 million tied to future performance milestones. This acquisition aims to enhance 3D Systems’ capabilities in the bioprinting of human organs, particularly focusing on the liver and other applications. Dr. Jordan Miller will join as Chief Scientist for Regenerative Medicine to lead this initiative, expanding the company's efforts alongside United Therapeutics in creating vital organ solutions. A conference call on October 28, 2021, will provide further details.
3D Systems (DDD) announced that it will release its third quarter 2021 financial results and file its Form 10-Q on November 8, 2021, after U.S. markets close. A conference call to discuss these results will take place on November 9, 2021, at 8:30 a.m. ET. Investors can participate via telephone or webcast. The company emphasizes its reliance on forward-looking statements, cautioning that actual results may differ due to various risks and uncertainties. More details can be found on their investor relations webpage.
Trilantic North America has acquired the On-Demand Manufacturing business from 3D Systems (NYSE: DDD), rebranding it as Quickparts. This strategic move is led by industry veteran Ziad Abou, who becomes CEO. Quickparts, recognized in digital manufacturing, aims to expand its services and enhance customer value with over 150 in-house 3D printers across North America and Europe. The acquisition highlights Trilantic's commitment to advancing Industry 4.0 technologies and better serving diverse markets.
FAQ
What is the current stock price of 3D Systems (DDD)?
What is the market cap of 3D Systems (DDD)?
What does 3D Systems Corp do?
What are the main segments of 3D Systems' business?
What recent innovations has 3D Systems introduced?
How is 3D Systems expanding its digital dentistry portfolio?
What is the significance of 3D Systems' recent debt repurchase?
How does 3D Systems impact the healthcare industry?
What are some of the industries served by 3D Systems?
Where does 3D Systems generate most of its revenue?
What is 3D Systems' approach to supporting customer demand?
How long has 3D Systems been in the 3D printing industry?
